**Specifications Table**TableSubject area*Chemistry, Biology, Phytochemistry, Analytical Chemistry, Medicinal Biology*More specific subject area*Pharmacognosy*Type of data*Tables, text file, figures*How data was acquired*FT-IR (Perkin-Elmer Frontier 286*^*™*^*), GC--MS (Thermo-Quest), NMR (Bruker), in vitro bioassays*Data format*Analyzed*Experimental factors*Structural elucidation and antitrypanosomal activities of novel compounds derived from medicinal plants*Experimental features*Thiosemicarbazones were sysnthesized from Cymbopogon schoenatus essential oil and fully characterized using GC--MS, FT-IR, and NMR and their* antiparasitic activities evaluated *in vitro* on *Trypanosoma brucei brucei* (*Tbb*)Data source location*Cotonou, Benin*Data accessibility*The data is available with this article*

**Value of the data**•4-phenyl semicarbazone (**[3)]{.ul}** and 4-phenyl thiosemicarbazone (**[4)]{.ul}** can be used as asantitrypanosomal drugs against sleeping sickness.•4-phenyl semicarbazone (**[3)]{.ul}** can be used with no cytotoxicity effect.•*Data shows that Cymbopogon schoenatus* essential Oil can be used as an antiparasitic agent.

1. Data {#s0005}
=======

The data of this study provides the chemical composition characteristics ([Supplementary data](#s0050){ref-type="sec"}), the antitrypanosomal activities and the cytotoxicity levels of novel *in situ* hemisynthesis of thiosemicarbazone derivatives from *Cymbopogon schoenatus* essential oil ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Analysis of the essential oil by GC-FID and GC--MS {#s0015}
-------------------------------------------------------

The GC-FID analysis was carried out on a FOCUS GC (Thermo Finigan; Milan, Italy) using the following operating conditions: HP 5MS column (30 m×0.25 mm, film thickness: 0.25 μm) (J&W Scientific Column of Agilent Technologies, USA); injection mode: splitless; injection volume: 1 µL (TBME solution); flow of split: 10 ml/min; splitless time: 0.80 min; injector temperature: 260 °C; oven temperature was programmed as following: 50 °C--250 °C at 6 °C/min and held at 250 °C for 5 min; the carrier gas was helium with a constant flow of 1.2 mL/min; FID detector temperature was 260 °C. The data were recorded and treated with the ChromCard software. The quantification was completed by the calculation of the areas under curve of the peaks (GC-FID, normalization process) and the identification of compounds by comparison of the retention indices (RI) with the references. The GC--MS analysis were carried out using a TRACE GC 2000 series (Thermo-Quest, Rodano, Italy), equipped with an autosampler AS2000 Thermo-Quest operating in the electronic impact mode at 70 eV. HP 5MS column (30 m×0.25 mm, film thickness: 0.25 μm). The coupling temperature of the GC was 260 °C and the temperature of the source of the electrons was 260 °C. The data were analyzed with the Xcalibur 1.1 software (ThermoQuest). The mass spectra of the peaks were analyzed and compared with references, literature and the NIST/EPA/NIH database. The individual components of the volatile oils were identified by comparison of their relative retention times with those of authentic standard references, computer matching against commercial library and custom proprietary library mass spectra made from pure substances and components of known oils. Mass spectrometry literature data were also used for the identification. Quantification (expressed as percentages) was carried after normalization using peak areas obtained by FID.

2.2. Hemi-synthesized compounds identification {#s0020}
----------------------------------------------

The melting points were taken on a fusionometer type *electrothermal 1A 9000*. The IR spectra were recorded on a Perkin-Elmer FTIR 286. The frequencies of absorption bands were expressed in cm^−1^. The NMR spectra were registered on a Bruker 500 in chloroform-d6 (CDCl~3~) or dimethylsulfoxide-d6 (DMSO-d6) which frequencies for ^1^H and ^13^C were 400 MHz and 100 MHz respectively. Chemical shifts were given in parts per million (ppm) relative to tetra-methyl silane (TMS) as an internal reference. Multiplicity was designated as singlet (s), triplet (t), doublet (d) and multiplet (m). MS spectrometric data of compounds were reported in APCI mode. The semicarbazones and thiosemicarbazones were synthesized by the following methods: Piperitone semicarbazone (**[1]{.ul}**): to a stirred mixture of 304 mg of *C. schoenantus* essential oil dissolved in 3 ml of ethanol at 95° was added 1 mmol (111.5 mg) of semicarbazide hydrochloride dissolved in 2 ml of distilled water. 5 drops of triethylamine were added to a mixture after a minute of stirring. Then crystals appeared after 5 min of agitation but the stirring was maintained for another hour. The resulting crystals were filtered, washed until neutral, dried, weighed and then recrystallized in ethanol ([Fig. 1](#f0005){ref-type="fig"}). Piperitone substituted semicarbazone and thiosemicarbazones (**[2]{.ul}**, **[3]{.ul}**, **[4]{.ul}**): To a stirring of the mixture of 304 mg of *C. schoenantus* essential oil dissolved in 3 ml of ethanol was added 1 mmol of semicarbazide or substituted (thio) semicarbazides dissolved in 3 ml of hydrochloric acid (1 N). After the appearance of crystals between one to three minutes, stirring was continued for one hour. The resulting crystals were filtered, washed until neutral, dried, weighed and recrystallized from ethanol ([Fig. 2](#f0010){ref-type="fig"}).

2.3. Bioassay tests {#s0025}
-------------------

The Antitrypanosomal activity, toxicity test, and cytotoxicity assay were done according to Räz et al. [@bib6], Sleet and Brendel [@bib7] and Stevigny et al. [@bib8], respectively.

Transparency document. Supplementary material {#s0040}
=============================================

Supplementary material.

Appendix A. Supplementary material {#s0050}
==================================

Supplementary material.
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###### 

Chemical composition of *Cymbopogon schoenantus* essential oil.

Table 1

  [a](#tbl1fna){ref-type="table-fn"}**Compounds**   [b](#tbl1fnb){ref-type="table-fn"}**RI**   **%Area**
  ------------------------------------------------- ------------------------------------------ -----------
  myrcene                                           991                                        0.18
  δ-2-carene                                        1000                                       19.38
  p-cymene                                          1025                                       0.13
  limonene                                          1030                                       3.16
  *Cis-*β-ocimene                                   1036                                       0.19
  *trans*-β-ocimene                                 1047                                       0.13
  *Cis-*menth-2-en-1-ol                             1126                                       1.02
  *trans*-menth-2-en-1-ol                           1144                                       0.68
  citronellal                                       1153                                       0.12
  α-terpineol                                       1196                                       1.29
  *trans*-piperitol                                 1210                                       0.37
  eucarvone                                         1249                                       0.22
  piperitone                                        1262                                       68.20
  β-elemene                                         1390                                       0.21
  β-caryophyllene                                   1421                                       0.40
  elemol                                            1548                                       1.20
  eranyle butyrate                                  1553                                       0.30
  carayophyllene oxide                              1584                                       0.20
  γ-eudesmol                                        1632                                       0.20
  α-cadinol                                         1656                                       0.53
  **Total**                                                                                    **98.11**

Compounds listed in order of elution from HP-5-MS column.

Retention indice (RI) on HP5-MS.

###### 

*in vitro* antitrypanosomal, cytotoxicity and toxicity against *A. salina* Leach, and selectivity indices of hemi-synthesized compounds.

Table 2

  **Composés**                                   **[1]{.ul}**     **[2]{.ul}**     **[3]{.ul}**     **[4]{.ul}**    
  ---------------------------------------------- ---------------- ---------------- ---------------- --------------- ----------------
  **Toxicity against*****A. salina*****Leach**   LC~50~ (μM)      373.20±6.60^c^   86.66±2.33^b^    85.52±2.28^b^   32.22±1.66^a^
  Activity                                       Not toxic        Not toxic        Not toxic        Toxic           
                                                                                                                      
  **Cytotoxicity (IC**~**50**~**μM)**            WI38 (μM)        481.48±6.69^c^   143.38±4.89^b^   80.95±9.15^a^   134.09±5.45^b^
  Activity                                       Not cytotoxic    Not cytotoxic    Not cytotoxic    Not cytotoxic   
  CHO (μM)                                       213.54±7.56^c^   21.16±1.37^a^    65.87±4.8^b^     65.35±4.02^b^   
  Activity                                       Not toxic        Cytotoxic        Moderate         Moderate        
                                                                                                                      
  ^**α**^**Selectivity indices**                 LC~50~/*tbb*     0.78             1.16             9.91            2.96
  WI38/ *tbb*                                    1.01             1.92             9.38             12.30           
  CHO/*tbb*                                      0.45             0.28             7.63             6.00            
  WI38/CHO                                       2.25             6.78             1.23             2.05            

**[1]{.ul}**: piperitone semicarbazone, **[2]{.ul}**: piperitone thiosemicarbazone, **[3]{.ul}**: piperitone 4-phenyl semicarbazone, **[4]{.ul}**: piperitone 4-phenyl thiosemicarbazone. *Tbb*: *Trypanosoma brucei brucei*, ^α^Selectivity index (SI): IC~50~ (WI38)/IC~50~ (Tbb), IC~50~: sample concentration providing 50% death of cells or parasites, LC~50~: sample concentration providing 50% death of larvae, WI38: human normal fibroblast cells, CHO: Chinese Hamster Ovary cells; Data in the same line followed by different letters are statistically different by Student׳s *t*-test (*P*\<0.05). Values are means±standard deviation of three separate experiments.
